| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ed2d3d4644164622e4f302cb7e3a823 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60 |
| filingDate |
2020-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77498fc13c37f4df4204fe2bf2cadb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dff1a3b2ae7c2d3a1d79d02cb2832b1 |
| publicationDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020339629-A1 |
| titleOfInvention |
Therapeutic constructs comprising cmet binding peptides |
| abstract |
Constructs comprising a plurality of peptides are provided and their use in treating cancer. The construct optionally connected to an organic scaffold, comprise ate least one peptide capable of targeting the tumor antigen cMet, at least two peptides targeting two additional extracellular tumor antigens and a toxin. Specific peptide sequences binding to the extracellular tumor antigens cMet or EGFR are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739163-B2 |
| priorityDate |
2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |